Angiogenic activity of endothelial progenitor cells through angiopoietin-1 and angiopoietin-2

Animal Cells and Systems

Volumn 20, Issue 3, 2016, Pages 118-129

  Siavashi, Vahid ^a   Sariri, Reyhaneh ^a   Nassiri, Seyed Mahdi ^b   Esmaeilivand, Masoumeh ^c   Asadian, Simin ^d   Cheraghi, Hadi ^b   Barekati Mowahed, Mazyar ^e   Rahbarghazi, Reza ^f  

^a UNIVERSITY OF GUILAN   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TORONTO   (Canada)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

angiogenic activity; Angiopoietin 1; angiopoietin 2; endothelial progenitor cells

Indexed keywords

EID: 84976407050     PISSN: 19768354     EISSN: 21512485     Source Type: Journal    
DOI: 10.1080/19768354.2016.1189961     Document Type: Article

References (41)

1. K.Abubaker, R.B.Luwor, R.Escalona, O.McNally, M.A.Quinn, E.W.Thompson, J.K.Findlay, N.Ahmed. 2014. Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden. Front Oncol. 9:75.
2. F.Arai, A.Hirao, M.Ohmura, H.Sato, S.Matsuoka, K.Takubo, K.Ito, G.Y.Koh, T.Suda. 2004. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 118:149–161. doi: 10.1016/j.cell.2004.07.004
3. T.Asahara, A.Kawamoto. 2004. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol. 287:C572–C579. doi: 10.1152/ajpcell.00330.2003
4. N.P.Brindle, P.Saharinen, K.Alitalo. 2006. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res. 98:1014–1023. doi: 10.1161/01.RES.0000218275.54089.12
5. J.Z.Chen, J.H.Zhu, X.X.Wang, J.H.Zhu, X.D.Xie, J.Sun. 2004. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol. 36:233–239. doi: 10.1016/j.yjmcc.2003.10.005
6. Y.H.Chen, S.J.Lin, F.Y.Lin, T.C.Wu, C.R.Tsao, P.H.Huang, P.L.Liu, Y.L.Chen, J.W.Chen. 2007. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes. 56:1559–1568. doi: 10.2337/db06-1103
7. C.C.Cheng, S.J.Chang, Y.N.Chueh, T.S.Huang, P.H.Huang, S.M.Cheng, T.N.Tsai, J.W.Chen, H.W.Wang. 2013. Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses. BMC Genom. 14:182. doi: 10.1186/1471-2164-14-182
8. D.J.Dumont, E.Bogdanovic, V.P.Nguyen. 2006. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization. J Cell Sci. 119:3551–3560. doi: 10.1242/jcs.03077
9. M.Felcht, R.Luck, A.Schering, P.Seidel, K.Srivastava, J.Hu, A.Bartol, Y.Kienast, C.Vettel, E.K.Loos. 2012. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest. 122:1991–2005. doi: 10.1172/JCI58832
10. + endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res. 98:e20–e25. doi: 10.1161/01.RES.0000205765.28940.93
11. S.Fukuhara, K.Sako, K.Noda, K.Nagao, K.Miura, N.Mochizuki. 2009. Tie2 is tied at the cell–cell contacts and to extracellular matrix by angiopoietin-1. Exp Mol Med. 41:133–139. doi: 10.3858/emm.2009.41.3.016
12. D.Grigoras, L.Pirtea, R.A.Ceausu. 2014. Endothelial progenitor cells contribute to the development of ovarian carcinoma tumor blood vessels. Oncol Lett. 7:1511–1514.
13. T.Hawighorst, M.Skobe, M.Streit, Y.-K.Hong, P.Velasco, L.F.Brown, L.Riccardi, B.Lange-Asschenfeldt, M.Detmar. 2002. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. Am J Pathol. 160:1381–1392. doi: 10.1016/S0002-9440(10)62565-5
14. – progenitors. Blood. 104:2010–2019. doi: 10.1182/blood-2003-12-4219
15. J.Hur, C.H.Yoon, H.S.Kim, J.H.Choi, H.J.Kang, K.K.Hwang, B.H.Oh, M.M.Lee, Y.B.Park. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 24:288–293. doi: 10.1161/01.ATV.0000114236.77009.06
16. A.Iwama, I.Hamaguchi, M.Hashiyama, Y.Murayama, K.Yasunaga, T.Suda. 1993. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun. 195:301–309. doi: 10.1006/bbrc.1993.2045
17. R.K.Jain. 2003. Molecular regulation of vessel maturation. Nat Med. 9:685–693. doi: 10.1038/nm0603-685
18. N.Jones, D.J.Dumont. 1998. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene. 17:1097–1108. doi: 10.1038/sj.onc.1202115
19. A.Kawamoto, H.Iwasaki, Kusano K, Murayama T, Oyamada A, Silver M, Hulbert C, Gavin M, Hanley A, Ma H, et al. 2006. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 14:2163–2169. doi: 10.1161/CIRCULATIONAHA.106.644518
20. K.Kobayashi, T.Kondo, N.Inoue, M.Aoki, M.Mizuno, K.Komori, J.Yoshida, T.Murohara. 2006. Combination of in vivo angiopoietin1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis. Arterioscler Thromb Vasc Biol. 26:1465–1472. doi: 10.1161/01.ATV.0000223865.64812.26
21. H.J.Lee, S.W.Bae, G.Y.Koh, Y.S.Lee. 2008. COMP-Ang1, angiopoietin-1 variant protects radiation-induced bone marrow damage in C57BL/6 mice. J Radiat Res. 49:313–320. doi: 10.1269/jrr.07064
22. I.B.Lobov, P.C.Brooks, R.A.Lang. 2002. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 99:11205–11210. doi: 10.1073/pnas.172161899
23. V.Martin, D.Liu, J.Fueyo, C.Gomez-Manzano. 2008. Tie2: a journey from normal angiogenesis to cancer and beyond. Histol Histopathol. 23:773–780.
24. E.Mohammadi, S.M.Nassiri, R.Rahbarghazi, V.Siavashi, A.Araghi. 2015. Endothelial juxtaposition of distinct adult stem cells activates angiogenesis signaling molecules in endothelial cells. Cell Tissue Res. 362:597–609. doi: 10.1007/s00441-015-2228-2
25. H.E.Moon, K.Byun, H.W.Park, J.H.Kim, J.Hur, J.S.Park, J.K.Jun, H.S.Kim, S.L.Paek, I.K.Kim. 2015. COMP-Ang1 potentiates EPC treatment of ischemic brain injury by enhancing angiogenesis through activating AKT-mTOR pathway and promoting vascular migration through activating Tie2-FAK pathway. Exp Neurobiol. 24:55–70. doi: 10.5607/en.2015.24.1.55
26. N.Mukai, T.Akahori, M.Komaki, Q.Li, T.Kanayasu-Toyoda, A.Ishii-Watabe, A.Kobayashi, T.Yamaguchi, M.Abe, T.Amagasa. 2008. A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res. 314:430–440. doi: 10.1016/j.yexcr.2007.11.016
27. T.J.Povsic, K.L.Zavodni, E.Vainorius, J.F.Kherani, P.J.Goldschmidt-Clermont, E.D.Peterson. 2009. Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations. Am Heart J. 157:335–344. doi: 10.1016/j.ahj.2008.10.010
28. P.C.Rae, R.Kelly, S.Egginton, J.C.St John. 2011. Angiogenic potential of endothelial progenitor cells and embryonic stem cells. Vasc Cell. 3:11. doi: 10.1186/2045-824X-3-11
29. J.L.Reinardy, D.M.Corey, C.Golzio, S.B.Mueller, N.Katsanis, C.D.Kontos. 2015. Phosphorylation of threonine 794 on Tie1 by Rac1/PAK1 reveals a novel angiogenesis regulatory pathway. PLoS ONE. 10:e0139614. doi: 10.1371/journal.pone.0139614
30. A.B.Salter, S.K.Meadows, G.G.Muramoto, H.Himburg, P.Doan, P.Daher, L.Russell, B.Chen, N.J.Chao, J.P.Chute. 2009. Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. Blood. 113:2104–2107. doi: 10.1182/blood-2008-06-162941
31. M.Scharpfenecker, U.Fiedler, Y.Reiss, H.G.Augustin. 2005. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 118:771–780. doi: 10.1242/jcs.01653
32. V.Siavashi, S.M.Nassiri, R.Rahbarghazi, R.Vafaei, R.Sariri. In press. ECM dependence of endothelial progenitor cell features. J Cell Biochem. doi:10.1002/jcb.25492
33. D.M.Smadja, I.Laurendeau, C.Avignon, M.Vidaud, M.Aiach, P.Gaussem. 2006. The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemostat. 4:2051–2058. doi: 10.1111/j.1538-7836.2006.02101.x
34. C.Suri, P.F.Jones, S.Patan, S.Bartunkova, P.C.Maisonpierre, S.Davis, T.N.Sato, G.D.Yancopoulos. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1171–1180. doi: 10.1016/S0092-8674(00)81813-9
35. N.Takakura, H.Yoshida, Y.Ogura, H.Kataoka, S.Nishikawa, S.I.Nishikawa. 1997. PDGFRα expression during mouse embryogenesis: immunolocalization analyzed by whole-mount immunohistostaining using the monoclonal anti-mouse PDGFRα antibody APA5. J Histochem Cytochem. 45:883–893. doi: 10.1177/002215549704500613
36. C.Urbich, S.Dimmeler. 2004. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 95:343–353. doi: 10.1161/01.RES.0000137877.89448.78
37. M.Vasa, S.Fichtlscherer, A.Aicher, K.Adler, C.Urbich, H.Martin. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 89:E1–E7. doi: 10.1161/hh1301.093953
38. B.Witzenbichler, P.C.Maisonpierre, P.Jones, G.D.Yancopoulos, J.M.Isner. 1998. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem. 273:18514–18521. doi: 10.1074/jbc.273.29.18514
39. M.C.Yoder. 2012. Human endothelial progenitor cells. Cold Spring Harb Perspect Med. 2:a006692. doi: 10.1101/cshperspect.a006692
40. Y.Yu, J.Varughese, L.F.Brown, J.B.Mulliken, J.Bischoff. 2001. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial Cells. Am J Pathol. 159:2271–2280. doi: 10.1016/S0002-9440(10)63077-5
41. H.Zeng, L.Li, J.X.Chen. 2012. Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts. PLoS ONE. 7:e35905. doi: 10.1371/journal.pone.0035905